Neil Almstead

Neil Almstead

Chief Technical Operations OfficeratPTC Therapeutics· In proxies 2022–2025

Pay in FY2025+36% from the year before · PTC Therapeutics stock +68.3% the same year

Neil Almstead was paid $3.2M in FY2025 (Dec), up 36%. PTC Therapeutics stock rose 68.3% that year.

Pay$100 in the stock at the end of FY21 → $191
Pay is from the Summary Compensation Table of each PTC Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PTC TherapeuticsPublic company · 4 yr
    • Chief Technical Operations Officer2022 – Present · 4 yrStock in role +54%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?